Community Oncology
Elsevier BV
About the journal
Community Oncology is a journal published by Elsevier BV in United States. It is listed in PUBMED according to the sources read. Facts are reproduced as recorded at their sources with their capture dates; PublishLens indicators are available after sign-in.
Basic facts
- Publisher
- Elsevier BV
- ISSN
- 2331-4435 · 1548-5315
- Country
- United States
- Access
- Not open access / not declared
- Declared peer-review model
- peer_review
Index listings
- PUBMED · 2008-11-01
- Indexing
- PUBMED
- APC
- —
- Declared review time (DOAJ)
- —
- Activity (OpenAlex)
- Dormant — no works recorded since 2013
- PublishLens list status
- Shown after sign-in
- Counts for promotion at your university?
- Choose your university and rank below ↓
Methodology signals (dated facts from their sources)
Details of the evaluation under the published methodology are shown to signed-in users (free).
Create a free account to view the evaluationJournal profile
Descriptive metadata from public sources (DOAJ, OpenAlex, PubMed) as of the capture date shown — contains no assessment or judgment.
Works in OpenAlex
1297
Last recorded publication year
2013
h-index
23
i10-index
60
From OpenAlex open data (CC0).
Editorial & policy3
- Observed digital preservation (Keepers registry)— snapshot 2026-10-05
- CLOCKSSPortico
- Open references deposited at Crossref
- 0%
- ORCID iDs in current deposits
- 0%
Identity & continuity1
- Source type
- journal
Classification(no data)
No data available to the platform for this group
No platform data for: Classification — absence is not a judgment about the journal.
Subject areas
- Healthcare Policy and Management
- Cancer Treatment and Pharmacology
- Cancer Treatment and Pharmacology
- Breast Cancer Treatment Studies
- Economic and Financial Impacts of Cancer
- Cancer survivorship and care
- Advances in Oncology and Radiotherapy
- Palliative and Oncologic Care
Show all subjects (75)
- Economic and Financial Impacts of Cancer
- Economic and Financial Impacts of Cancer
- Health Systems, Economic Evaluations, Quality of Life
- Health Systems, Economic Evaluations, Quality of Life
- Advances in Oncology and Radiotherapy
- BRCA gene mutations in cancer
- Advances in Oncology and Radiotherapy
- Lung Cancer Treatments and Mutations
- Lung Cancer Treatments and Mutations
- Pharmaceutical Economics and Policy
- Lung Cancer Treatments and Mutations
- Chronic Lymphocytic Leukemia Research
- Breast Cancer Treatment Studies
- Colorectal Cancer Treatments and Studies
- Colorectal Cancer Treatments and Studies
- Breast Cancer Treatment Studies
- Colorectal Cancer Treatments and Studies
- HER2/EGFR in Cancer Research
- HER2/EGFR in Cancer Research
- Bone health and treatments
- Lung Cancer Diagnosis and Treatment
- Health Services Management and Policy
- Chronic Lymphocytic Leukemia Research
- Global Cancer Incidence and Screening
- Chronic Lymphocytic Leukemia Research
- Cancer Treatment and Pharmacology
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Lymphoma Diagnosis and Treatment
- Patient-Provider Communication in Healthcare
- Neutropenia and Cancer Infections
- Healthcare Quality and Management
- BRCA gene mutations in cancer
- Breast Lesions and Carcinomas
- BRCA gene mutations in cancer
- Cancer Genomics and Diagnostics
- Cancer Genomics and Diagnostics
- Electronic Health Records Systems
- Colorectal Cancer Surgical Treatments
- Multiple Myeloma Research and Treatments
- Science, Research, and Medicine
- Science, Research, and Medicine
- HER2/EGFR in Cancer Research
- Palliative Care and End-of-Life Issues
- Chronic Myeloid Leukemia Treatments
- Palliative Care and End-of-Life Issues
- Chronic Myeloid Leukemia Treatments
- Healthcare Policy and Management
- Healthcare Policy and Management
- Biotechnology and Related Fields
- Biotechnology and Related Fields
- Prostate Cancer Treatment and Research
- Biomedical Ethics and Regulation
- Prostate Cancer Treatment and Research
- Biomedical Ethics and Regulation
- Cancer Diagnosis and Treatment
- Pharmaceutical Economics and Policy
- Primary Care and Health Outcomes
- Chemotherapy-related skin toxicity
- Chemotherapy-related skin toxicity
- Cancer Diagnosis and Treatment
- Pharmaceutical Economics and Policy
- Primary Care and Health Outcomes
- Bone health and treatments
- Bone health and treatments
- Neutropenia and Cancer Infections
- Neutropenia and Cancer Infections
Community confirmations — what users saw in MJL or Scopus Sources; not platform verification and never part of any score.
The journal's record in other sources:Web of Science MJLDOAJ